ライフサイエンスコーパス: soy protein

1 ysis suggest a hypocholesterolemic effect of soy protein.

2 adlayers in the same thickness range as pure soy protein.

3 nces between intact and partially hydrolyzed soy protein.

4 e of their relatively high concentrations in soy protein.

5 and a beverage containing 0, 5, 10, or 20 g soy protein.

6 d included egg white, meat, and phytate-free soy protein.

7 humans, nor when amino acids replace intact soy protein.

8 vestigated to reduce the immunoreactivity of soy protein.

9 ity of hair coverage comparing to unmodified soy protein.

10 l cellulose, rhamnolipid biosurfactants, and soy protein.

11 ly assigned into 1 of 4 intervention groups: soy protein (18 g) + isoflavone tablets (105 mg isoflavo

12 The effects of soy protein (40 g/d) containing moderate and higher conc

13 randomly assigned to 1 of 4 treatments with soy protein (40 g/d) isolate (SPI): low phytate/low isof

14 ged 47-72 y were randomly assigned to 1 of 4 soy protein (40 g/d) isolate treatments: native phytate

15 ked cookies were as follows: casein, 84-90%; soy protein, 80-88%, and gluten, 80-90%.

16 s based on soluble protein: casein, 95-107%; soy protein, 92-97%, and gluten, 96-99%.

17 Soy protein, a rich source of isoflavones, fed immediate

18 establish whether the dietary isoflavones in soy protein affect cardiovascular function.

19 Neither venlafaxine nor soy protein alone or in combination had a significant ef

20 ontaining 66 mg of isoflavones (SPI) or 15 g soy protein alone without isoflavones (SP) daily for thr

21 of human subjects with or without diabetes, soy protein also appears to moderate hyperglycemia and r

22 provide evidence that long-term ingestion of soy protein alters steroid hormone values, but it sugges

23 ined and compared with that of beef protein, soy protein and cow whey protein.

24 not clear whether the beneficial effects of soy protein and flaxseed are due to isoflavones (daidzei

25 The data was compared to adsorption of soy protein and glutamic acid as common ingredients.

26 okies (67-90%, 66-95% and 66-88% for casein, soy protein and gluten, respectively).

27 of 91-108%, 88-127% and 85-108% for casein, soy protein and gluten, respectively.

28 lar proteins, ovalbumin, beta-lactoglobulin, soy protein and human serum albumin.

29 Because soy protein and isoflavones (either alone or together) d

30 of this study was to determine the effect of soy protein and isoflavones on plasma lipid concentratio

31 tudies have examined the separate effects of soy protein and isoflavones.

32 milar results were also found for intakes of soy protein and isoflavones.

33 uld physically modify secondary structure of soy protein and lead to about 23.6% and 43.3% improvemen

34 status, but our results suggest that dietary soy protein and low iron stores may protect perimenopaus

35 Compared with carbohydrate controls, soy protein and milk protein supplementations were signi

36 e was to evaluate the independent effects of soy protein and soy-derived isoflavones on plasma antiox

37 Isolated soy protein and textured vegetable protein consisted of

38 to evaluate the long-term effect of dietary soy protein and/or soy isoflavone consumption on skeleta

39 re susceptible to protein carbonylation than soy proteins and globular were more susceptible than fib

40 Soy-protein and isoflavones are dissociated by water rin

41 p to concentrations of 10 ppm for casein and soy protein, and 100 ppm for gluten.

42 single and multiple allergens (i.e., casein, soy protein, and gluten) in an incurred food matrix befo

43 he isoflavones in modest amounts of ingested soy protein are biotransformed by intestinal microflora,

44 gs of this study suggest that isoflavones in soy protein are responsible for its bone-sparing effects

45 tudy was to determine whether isoflavones in soy protein are responsible for this bone-protective eff

46 Under the conditions of the study, providing soy protein as half of the daily protein intake had no d

47 als and humans suggest that the ingestion of soy protein associated with isoflavones and flaxseed ric

48 Intake of soy protein at both isoflavone concentrations for 6 mo m

49 a-estradiol or genistein (a phytoestrogen in soy protein-based diets), and neonatal exposure of litte

50 duction being most pronounced in animals fed soy protein-based diets.

51 in pcy animals, with the effects of dietary soy protein being most pronounced in female animals fed

52 heir infants consumed one daily serving of a soy protein beverage for 2-4 d and collected their own m

53 pressure in healthy rats fed a diet based on soy protein, but influences small artery function.

54 in reduction were significant in animals fed soy protein, but not in those fed casein as the protein

55 Soy protein, but not venlafaxine, improved measures of Q

56 The effects of dietary soy protein compared to casein were examined in male and

57 ready-to-use supplementary food (RUSF) with soy protein compared with a novel RUSF containing dairy

58 was reduced in animals fed diets containing soy protein compared with those fed diets with animal pr

59 s to determine the independent effect of the soy protein components isoflavones and phytate on CVD ri

60 objective was to ascertain the effect of the soy protein components isoflavones and phytate on CVD ri

61 ctional properties and isoflavone profile of soy protein concentrate.

62 Alcohol-washed soy-protein concentrates contained few isoflavones.

63 tween soy products (other than soy milk) and soy protein consumption (protein derived from soy beans

64 Soy protein consumption may help protect against these r

65 Soy-protein consumption is known to reduce plasma total

66 tep I diet with 40 g protein/d from isolated soy protein containing 1.39 mg isoflavones/g protein (IS

67 tep I diet with 40 g protein/d from isolated soy protein containing 2.25 mg isoflavones/g protein (IS

68 tosterone <12 nmol/L, were treated with 15 g soy protein containing 66 mg of isoflavones (SPI) or 15

69 NCEP Step 1 diet with protein from isolated soy protein containing high amounts of isoflavones (ISP9

70 compared the effects of moderate intakes of soy protein containing intact phytoestrogens (high-isofl

71 ted the hypothesis that supplementation with soy protein containing isoflavones decreases colorectal

72 Supplementation with soy protein containing isoflavones does not reduce color

73 s the main protein source and the other with soy protein containing isoflavones, on protein markers o

74 NCEP Step 1 diet with protein from isolated soy protein containing moderate amounts of isoflavones (

75 The long-term clinical effects of soy protein containing various amounts of isoflavones on

76 The long-term clinical effects of soy protein containing various concentrations of isoflav

77 We examined the effects of ingestion of soy protein containing various concentrations of isoflav

78 either a milk protein (Milk group) or 1 of 2 soy proteins containing either trace amounts of isoflavo

79 To determine whether soy protein could enhance the hypocholesterolemic effect

80 g agents from triethanolamine (TEA) modified soy protein could substitute poly(vinyl alcohol)(PVA) si

81 ndings show that consuming as little as 20 g soy protein/d instead of animal protein for 6 wk reduces

82 -0.2 mm Hg) in women who consumed > or =25 g soy protein/d than in women consuming <2.5 g/d.

83 ardless of dietary isoflavones (P = 0.0003), soy protein did not significantly affect most individual

84 ese (fa/fa) and lean (Fa/Fa) rats were fed a soy protein diet ad libitum under barrier conditions fro

85 Compared with the casein diet, the soy protein diet had a similar oxidation level, but high

86 Subjects were fed either an NCEP Step I soy-protein diet or an NCEP Step I animal protein diet f

87 Our previous studies showed that a soy-protein diet prevents ovariectomy-induced bone loss.

88 Regardless of plasma lipid status, the soy-protein diet was associated with a statistically sig

89 Soy protein diets containing varying amounts of genistei

90 Soy protein directly lowers blood low-density lipoprotei

91 Our results indicate that soy protein enhances the hypocholesterolemic effect of t

92 Particular preparations of hydrolyzed soy proteins, especially Soy Peptone A3, have been found

93 he unattenuated correlation (95% CI) between soy protein estimates from 24-h recalls and FFQs was 0.5

94 Soy protein estimates from FFQs were compared against re

95 We assessed the validity of soy protein estimates from food-frequency questionnaires

96 Soy protein estimates from questionnaire were significan

97 as the outcome showed that isoflavones, not soy protein, exerted the effect.

98 , 0.8), adjusted for age, menopausal status, soy protein, fibroadenoma history, family breast cancer,

99 found in high concentrations in soybeans and soy-protein foods, may have beneficial effects in the pr

100 w-phytate formulas with intact or hydrolyzed soy protein for 4 mo and plasma zinc and copper were mea

101 n hypothesis, which states that substituting soy protein for animal protein in diabetes patients resu

102 Furthermore, substituting soy protein for animal protein should have therapeutic v

103 tionnaire were significantly correlated with soy protein from 24-h recalls and urinary excretion of d

104 ct phytoestrogens (high-isoflavone diet) and soy protein from which most of the phytoestrogens had be

105 Compared with soy protein from which most of the phytoestrogens have b

106 Industrial weaving results showed TEA-soy protein had relative weaving efficiency 3% and 10% h

107 Soy protein has been shown to be hypocholesterolemic, pa

108 In animal models of obesity and diabetes, soy protein has been shown to reduce serum insulin and i

109 Replacing animal protein with soy protein has been shown to reduce total and LDL-chole

110 In summary, the isoflavone content of soy protein has no influence on blood pressure in health

111 that populations consuming large amounts of soy protein have a reduced incidence of coronary heart d

112 from cherry pomace, encapsulated in whey and soy proteins, have been incorporated in cookies, replaci

113 iologically active compounds associated with soy protein; however, the precise mechanism and the comp

114 Casein and soy protein HPDs did not induce inflammation, but differ

115 to characterize the antioxidant capacity of soy protein hydrolysates (SPH) during sequential ultrafi

116 the available evidence, we are proposing the soy-protein hypothesis, which states that substituting s

117 dy-2 FFQ is a valid instrument for assessing soy protein in a population with a wide range of soy int

118 osteoporosis led us to examine the effect of soy protein in reversing established bone loss.

119 However, the hypocholesterolemic effect of soy protein in subjects with a blood total cholesterol c

120 Although allergies to cow's milk, egg, or soy proteins, in contrast to peanut and tree nut allerge

121 quintile were 0.41 (95% CI: 0.25, 0.70) for soy protein intake and 0.44 (95% CI: 0.26, 0.73) for iso

122 Correlation coefficients between soy protein intake from 24-h recalls and urinary isoflav

123 atio associated with the highest quartile of soy protein intake was 0.71 (95% confidence interval [CI

124 Soy protein intake was inversely associated with both sy

125 antioxidant performance was 10% higher with soy protein intake, regardless of dietary isoflavones (P

126 women in the lowest and highest quartiles of soy protein intake.

127 L-cholesterol concentrations in women with a soy-protein intake >/=6 g/d was 12.4% lower than that in

128 equired to critically examine the effects of soy-protein intake on the renal function of diabetes pat

129 Some studies suggest that the effects of soy-protein intake resemble those of a low-protein diet.

130 Soy-protein intake was associated with a significant red

131 Soy-protein intake was inversely associated with total a

132 The intake of whey, compared with casein and soy protein intakes, stimulates a greater acute response

133 Some studies suggest that, when soy protein is fed, cholesterol absorption or bile acid

134 Soy protein is rich in isoflavones, which are a class of

135 Soy protein isolate (but not other soy products or compo

136 aining 20 g of protein in the form of either soy protein isolate (n=87) or, as placebo, calcium casei

137 nteers consumed PJ alone or PJ premixed with soy protein isolate (PJSP).

138 nked polymers of whey protein isolate (WPI), soy protein isolate (SPI) and casein (CN) and their bina

139 loped from carboxymethyl chitosan (CMCS) and soy protein isolate (SPI) by a simple ionic gelation met

140 ulating peptides derived from Flavourzyme(R)-soy protein isolate (SPI) hydrolysate (F-SPIH).

141 xplore the lipolysis-stimulating activity of soy protein isolate (SPI) hydrolysate using 3T3-L1 adipo

142 Substitution of casein with soy protein isolate (SPI) in the HF diet (HF-SPI) preven

143 Soy protein isolate (SPI) may be one such dietary factor

144 een suggested that the beneficial effects of soy protein isolate (SPI) on bone quality are due to eit

145 y, physicochemical and sensory properties of soy protein isolate (SPI) was studied.

146 ith either whey protein concentrate (WPC) or soy protein isolate (SPI), as the carrier agents.

147 act with a protein-rich food matrix, such as soy protein isolate (SPI), we have developed a method to

148 Edible films prepared from soy protein isolate (SPI), with and without the phenolic

149 hey protein isolate (WPI), gelatin (Gel) and soy protein isolate (SPI).

150 In conclusion, premixing soy protein isolate and PJ did not affect the bioavailab

151 We investigated the effect of mixing soy protein isolate and pomegranate juice (PJ) on the bi

152 in-water emulsions prepared with 4% (w/v) of soy protein isolate and soybean oil (10 and 20%, v/v) we

153 and its oil-in-water emulsion stabilized by soy protein isolate at 55 degrees C were investigated.

154 e enriched with isoflavones (soy-plus diet), soy protein isolate devoid of isoflavones (soy-minus die

155 Soy protein isolate down-regulates caveolin-1 expression

156 ing intake of one dose of an isoflavone-rich soy protein isolate drink, the early morning blood level

157 n their regular diet and after one dose of a soy protein isolate drink.

158 three 1-mo controlled dietary interventions: soy protein isolate enriched with isoflavones (soy-plus

159 n of a beverage powder supplement containing soy protein isolate for 2 years following radical prosta

160 lbumin as the source of protein (casein), 2) soy protein isolate from which the isoflavones were alco

161 Spray dried matrices produced with soy protein isolate had the highest concentration of pol

162 Soy protein isolate more efficiently captured and stabil

163 The effect of the presence of ovalbumin and soy protein isolate on lipolysis and oxidation taking pl

164 ge were fed purified diets containing either soy protein isolate or casein given at a level of 17.4 o

165 phytochemical concentrate at 1%, or dietary soy protein isolate were reduced by 40% (P < 0.007), 48%

166 eat flour, chickpea flour, coconut flour and soy protein isolate with aqueous wild blueberry pomace e

167 rmine the effects of 24 wk of consumption of soy protein isolate with isoflavones (80.4 mg/d) in atte

168 1.0% of the diet; and (e) AIN-76A diet with soy protein isolate, 20% by weight.

169 vity than either whey protein concentrate or soy protein isolate, at each of the pH values tested.

170 enistein, soy phytochemical concentrate, and soy protein isolate, respectively, to inhibit the growth

171 during 1999-2001, evaluating the effects of soy protein isolate, soy foods, and purified isoflavones

172 and high: 128.7 +/- 15.7 mg/d), provided as soy protein isolate, were consumed for 3 menstrual cycle

173 SPH was obtained by enzymatic hydrolysis of soy protein isolate.

174 The objective was to determine the effect of soy-protein isolate (SPI) intake and iron indexes on pla

175 s after the consumption of a drink made with soy-protein isolate.

176 These formulas are manufactured from soy protein isolates and contain significant amounts of

177 Here we present new information that soy protein isolates containing increasing concentration

178 Depending on processing, soy protein isolates vary widely in concentrations of ge

179 esis we conducted experiments in which these soy protein isolates were fed to athymic mice implanted

180 onsistent with the isoflavone composition of soy protein isolates.

181 ived 50 g protein/d, which included isolated soy protein (ISP) and casein, respectively, in the follo

182 oughout three 93-d periods of daily isolated soy protein (ISP) consumption providing an average of 7.

183 ein from nonfat dry milk (control), isolated soy protein (ISP) containing 56 mg isoflavones (ISP56),

184 inantly small trials, an increased intake of soy protein lowered blood pressure.

185 steroid hormone values, but it suggests that soy protein may have small effects on thyroid hormone va

186 activity and differentiation; diets high in soy protein may help prevent high dietary fat-induced bo

187 We compared the effect of soy protein, milk protein, and carbohydrate supplementat

188 al participants were assigned to take 40 g/d soy protein, milk protein, or carbohydrate supplementati

189 We evaluated the amount of soy protein needed to reduce blood lipids in moderately

190 ificant only in females, and that effects of soy protein on cyst score were significant only in anima

191 en main effects revealed that the effects of soy protein on kidney size were significant only in fema

192 The magnitude of the effect of soy protein on lipoprotein concentrations is variable.

193 the efficacy of isoflavones (extracted from soy protein) on bone mineral density (BMD) in nonosteopo

194 l cellulose, rhamnolipid biosurfactants, and soy protein) on the aggregation and transport behavior o

195 ult soy food consumption, measured either by soy protein or isoflavone intake, was inversely associat

196 Soy protein or its components may protect against the at

197 No significant effects were identified for soy protein or milk basic protein on lumbar spine BMD.

198 Soy food intake, as measured by either soy protein or soy isoflavone intake, was inversely asso

199 Diets relatively high in soy protein or soy-derived isoflavones have little effec

200 humans have been reported after ingestion of soy protein or various extracts of soy, or both.

201 is study tested whether soybean isoflavones, soy protein, or both alter calcium metabolism in postmen

202 3-wk isocaloric supplementation with casein, soy protein, or maltodextrin as a control.

203 fects of traditional soy foods (e.g., tofu), soy protein, or urinary excretion of phytoestrogens.

204 whether this property is attributable to the soy protein per se or to associated dietary isoflavones.

205 ts (105 mg isoflavone aglycone equivalents), soy protein + placebo tablets, control protein + isoflav

206 o pill, venlafaxine and milk protein powder, soy protein powder and placebo pill, or venlafaxine and

207 powder and placebo pill, or venlafaxine and soy protein powder.

208 +ISO) or a control group (ethanol-extracted soy-protein powder containing 3 mg isoflavones; -ISO).

209 When soy-protein powder was fed at 0, 5, 10, and 20 g/d (0-36

210 cal trials have suggested that the intake of soy protein reduces blood cholesterol.

211 However, the minimum amount of soy protein required for significant reduction of blood

212 report that long-term feeding of rats with a soy protein-rich (SP) diet during gestation and adult li

213 Different soy protein (S) or whey protein (W) blends with maltodex

214 However, soy protein sizes lacked film flexibility and adhesion f

215 ol extracted (SPI-), or 3) isoflavone-intact soy protein (SPI+).

216 - and LDL-cholesterol lowering between the 2 soy-protein supplements suggests an effect attributable

217 ium seen with the consumption of an isolated soy protein than with that of an isolated milk protein w

218 idence have suggested that the components of soy protein that lower lipid concentrations are extracta

219 based edible products (soy extract, textured soy protein, transgenic soybeans, and whole soy flour) w

220 likely attributable to the various forms of soy protein used and to unrecognized shifts in dietary f

221 was to identify ACE inhibitory peptides from soy proteins using LC-MS/MS coupled with quantitative st

222 Among soy users, mean (+/- SD) soy protein values were 12.12 +/- 10.80 g/d from 24-h re

223 Overall, animals fed soy protein versus casein had 28% lower (P = 0.0037) rel

224 ecently evaluated the relative effect of the soy protein versus the alcohol-extractable components of

225 However, soy protein was associated with modestly lower concentra

226 The hypocholesterolemic effect of soy protein was found to be independent of age, body wei

227 Soy protein was hydrolyzed by Alcalase following respons

228 st bean gums, potato fiber, milk, potato and soy proteins) were added to tomato sauce to investigate

229 Whether consumption of genistein from soy protein will have similar effects on estrogen-depend

230 Soy protein with good biodegradability showed potential

231 t of the phytoestrogens have been extracted, soy protein with intact phytoestrogens increases HDL-cho

232 Our previous study indicated that soy protein with isoflavones lessened lumbar spine bone

233 studies have directly examined the effect of soy protein with isoflavones on bone or bone turnover in

234 = 0.027), and ferritin (P = 0.029), whereas soy protein with native isoflavones had no effect on any

235 Soy protein with native phytate significantly reduced tH

236 ceived diets in which casein was replaced by soy protein with normal (OVX+SOY) or reduced (OVX+SOY-)

237 -based diet (OVX+CASEIN), ovariectomized fed soy protein with normal isoflavone content (OVX+SOY), an

238 ne content (OVX+SOY), and ovariectomized fed soy protein with reduced isoflavone content (OVX+SOY-).

239 These results indicate that soy protein, with different amounts of isoflavones, may